Fujifilm Corporation is working towards improving the development of nucleic acid therapeutics by using liposomal drug delivery systems. The liposomal drug delivery systems are created from its knowledge in advanced nanodispersion and analytical technologies. The drug delivery formulation is also used in its anti-cancer drug candidate “FF-10832,” a liposomal gemcitabine formulation, which is being evaluated in a U.S. Phase 1 clinical trial. In support of these efforts, Fujifilm ha...